Tausch et al., 2017 - Google Patents
Evidence for complex formation of the Bacillus cereus haemolysin BL components in solutionTausch et al., 2017
View HTML- Document ID
- 15797983587407213403
- Author
- Tausch F
- Dietrich R
- Schauer K
- Janowski R
- Niessing D
- Märtlbauer E
- Jessberger N
- Publication year
- Publication venue
- Toxins
External Links
Snippet
Haemolysin BL is an important virulence factor regarding the diarrheal type of food poisoning caused by Bacillus cereus. However, the pathogenic importance of this three- component enterotoxin is difficult to access, as nearly all natural B. cereus culture …
- 241000193755 Bacillus cereus 0 title abstract description 83
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tausch et al. | Evidence for complex formation of the Bacillus cereus haemolysin BL components in solution | |
| Ohtani et al. | Regulation of toxin production in Clostridium perfringens | |
| Freedman et al. | Clostridium perfringens enterotoxin: action, genetics, and translational applications | |
| Ramarao et al. | The pore-forming haemolysins of Bacillus cereus: a review | |
| Sakurai et al. | Clostridium perfringens iota-toxin: structure and function | |
| Rocha et al. | Interaction between Shiga toxin and monoclonal antibodies: binding characteristics and in vitro neutralizing abilities | |
| Jessberger et al. | Binding to the target cell surface is the crucial step in pore formation of hemolysin BL from Bacillus cereus | |
| Romano et al. | Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity | |
| He et al. | A single-step purification and molecular characterization of functional Shiga toxin 2 variants from pathogenic Escherichia coli | |
| Locht et al. | The history of pertussis toxin | |
| Sadeghnezhad et al. | Identification of new DR5 agonistic nanobodies and generation of multivalent nanobody constructs for cancer treatment | |
| Davies et al. | Variations in the botulinum neurotoxin binding domain and the potential for novel therapeutics | |
| Zhu et al. | Mbov_0503 encodes a novel cytoadhesin that facilitates Mycoplasma bovis interaction with tight junctions | |
| Reppin et al. | High affinity binding of Escherichia coli cytotoxic necrotizing factor 1 (CNF1) to Lu/BCAM adhesion glycoprotein | |
| Fan et al. | The novel clostridial neurotoxin produced by strain IBCA10-7060 is immunologically equivalent to BoNT/HA | |
| Pernil et al. | Amino acid transporters and release of hydrophobic amino acids in the heterocyst-forming cyanobacterium Anabaena sp. strain PCC 7120 | |
| Rudenko et al. | A monoclonal antibody against the C-terminal domain of Bacillus cereus hemolysin II inhibits HlyII cytolytic activity | |
| Jessberger et al. | Characteristics of the protein complexes and pores formed by Bacillus cereus hemolysin BL | |
| Sharma et al. | Soluble T cell receptor Vβ domains engineered for high-affinity binding to staphylococcal or streptococcal superantigens | |
| Li et al. | Functional el-hn fragment as a potent candidate vaccine for the prevention of botulinum neurotoxin serotype e | |
| Zai et al. | Quantitative determination of lethal toxin proteins in culture supernatant of human live anthrax vaccine bacillus anthracis A16R | |
| Lee et al. | Expression of cholera toxin (CT) and the toxin co-regulated pilus (TCP) by variants of ToxT in Vibrio cholerae strains | |
| Kucinskaite-Kodze et al. | Mapping of recognition sites of monoclonal antibodies responsible for the inhibition of pneumolysin functional activity | |
| Kim et al. | Functional expression of the recombinant spike receptor binding domain of SARS-CoV-2 Omicron in the periplasm of Escherichia coli | |
| Xue et al. | Mycoplasma suis alpha-enolase subunit vaccine induces an immune response in experimental animals |